Ancora Advisors, LLC Northwest Biotherapeutics Inc Transaction History

Ancora Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.66 - $1.15 $19,140 - $33,350	29,000 Added 5.84%	526,000 $413,000
Q2 2022 Aug 15, 2022	BUY	$0.63 - $1.91 $76,135 - $230,823	120,850 Added 32.13%	497,000 $313,000
Q1 2022 May 16, 2022	BUY	$0.7 - $0.98 $262,605 - $367,647	375,150 Added 37515.0%	376,150 $262,000
Q1 2022 May 13, 2022	SELL	$0.7 - $0.98 $262,605 - $367,647	-375,150 Reduced 99.73%	1,000 $1,000
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.26 $225,090 - $472,689	375,150 Added 37515.0%	376,150 $263,000
Q1 2021 May 14, 2021	BUY	$1.32 - $1.63 $1,320 - $1,630	1,000 New	1,000 $1,000

674K

Ticker NWBO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,037,230,016
Market Cap $280M
Description
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.